FIELD: medicine.
SUBSTANCE: method involves studying blood serum lipid spectrum with phospholipid and fatty acid composition being determined in venous blood erythrocyte lipids and lipid peroxidation values in blood serum. Membrane-stabilizing therapy, absorbing lipid-correcting therapy and complex lipid-correcting and membrane-acting therapy are administered depending on factor values under study.
EFFECT: enhanced effectiveness of individual therapy selection.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTION OF REHABILITATION THERAPY FOR PATIENTS WITH CHRONICAL CHOLECYSTITIS IN REMISSION PHASE | 2007 |
|
RU2347571C2 |
| METHOD FOR REHABILITATION TREATMENT PATIENTS SUFFERING FROM ROOTED PYELONEPHRITIS | 2005 |
|
RU2297231C2 |
| AGENT WITH LIPID-CORRECTING AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2309763C2 |
| PREPARATION BEING OF LIPID-CORRECTING, HYPOCOAGULATIVE AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2302248C2 |
| METHOD OF MEDICAL REHABILITATION OF PATIENTS SUFFERING ARTERIAL HYPERTENSION WITH METABOLIC DISORDERS | 2008 |
|
RU2403922C2 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD FOR APPLYING RESTORATION THERAPY TO CHRONIC PYELONEPHRITIS PATIENTS | 2003 |
|
RU2250771C2 |
| METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS | 2020 |
|
RU2737416C1 |
